Clinicopathological features | CD147 expression | MMP-11 expression | ||||
---|---|---|---|---|---|---|
Positive (%) | Negative (%) | P value | Positive (%) | Negative (%) | P value | |
Gender | ||||||
 Male | 83 (64.34) | 46 (35.66) | 0.377 | 99 (76.74) | 30 (23.26) | 0.892 |
 Female | 52 (58.43) | 37 (41.57) | 69 (77.53) | 20 (22.47) | ||
Age (years) | ||||||
 <60 | 57 (57.58) | 42 (42.42) | 0.228 | 77 (77.78) | 22 (22.22) | 0.819 |
 ≥60 | 78 (65.53) | 41 (34.45) | 91 (76.47) | 28 (23.53) | ||
Differentiation | ||||||
 Poor | 26 (66.67) | 13 (33.33) | 0.501 | 32 (82.05) | 7 (17.95) | 0.414 |
 Moderate-well | 109 (60.89) | 70 (39.11) | 136 (75.98) | 43 (24.02) | ||
Size | ||||||
 <4 cm | 62 (59.62) | 42 (40.38) | 0.502 | 81 (77.88) | 23 (22.12) | 0.783 |
 ≥4 cm | 73 (64.04) | 41 (35.96) | 87 (76.32) | 27 (23.68) | ||
Lymphovascular invasion | ||||||
 Absent | 93 (62.42) | 56 (37.58) | 0.827 | 110 (73.83) | 39 (26.17) | 0.095 |
 Present | 42 (60.87) | 27 (39.13) |  | 58 (84.06) | 11 (15.94) |  |
Depth of invasion | ||||||
 T1/T2 | 16 (48.48) | 17 (51.52) | 0.084 | 22 (66.67) | 11 (33.33) | 0.123 |
 T3/T4 | 119 (64.32) | 66 (35.68) | 146 (78.92) | 39 (21.08) | ||
Lymph node metastasis | ||||||
 N0 | 47 (52.81) | 42 (47.19) | 0.021 | 62 (69.66) | 27 (30.34) | 0.031 |
 N1–2 | 88 (68.22) | 41 (31.78) | 106 (82.18) | 23 (17.83) | ||
Distant metastasis | ||||||
 M0 | 53 (63.86) | 30 (36.14) | <0.001 | 74 (69.81) | 32 (30.19) | 0.013 |
 M1 | 53 (39.26) | 82 (60.74) | 94 (83.93) | 18 (16.07) | ||
TNM stage | ||||||
 I + II | 37 (49.33) | 38 (50.67) | 0.006 | 52 (69.33) | 23 (30.67) | 0.049 |
 III + IV | 98 (68.53) | 45 (31.47) | 116 (81.11) | 27 (18.89) |